Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
LYSODREN Tabl 500 mg Fl 100 Stk
Drug
Lysodren, Tabletten
Symptomatische Behandlung des fortgeschrittenen (nicht-resezierbaren, metastasierenden oder rezidivierenden) Nebennierenrindenkarzinoms
07.16.2. – hormones
HAM – Human medicine
TAB – Tablet
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
11/30/2009
12/31/9999
Dosage strength
Lysodren, Tabletten
Symptomatische Behandlung des fortgeschrittenen (nicht-resezierbaren, metastasierenden oder rezidivierenden) Nebennierenrindenkarzinoms
01
Z – approved
Package
7680573460017
In trade from / since 11/30/2009
A/R – Authorised / referenced
100 tablet(s)
001
Z – approved
Declaration
Component
500 mg mitotanum
maydis amylum
cellulosum microcristallinum
macrogolum 3350
silica colloidalis anhydrica
cellulosum microcristallinum
macrogolum 3350
silica colloidalis anhydrica
Authorisation holder
7609999319204
EffRx Pharmaceuticals SA
Wolleraustrasse 41B
8807 Freienbach (SZ)
Wolleraustrasse 41B
8807 Freienbach (SZ)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.